RDHL · RedHill Biopharma Ltd. · Documents
Market Cap
$3.75M
Shares
8.89M
Volume · Oct 23
108.14K
Avg daily vol (3M)
2.04M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2023-06-12 | — | |
| 6-K | — | 2023-05-22 | — | |
| 6-K | — | 2023-05-16 | 2023-05-15 | |
| 6-K | — | 2023-05-09 | — | |
| 6-K | — | 2023-05-04 | — | |
| 6-K | — | 2023-05-01 | — | |
| 20-F | — | 2023-04-28 | 2022-12-31 | |
| 6-K | — | 2023-04-28 | — | |
| 6-K | — | 2023-04-21 | — | |
| 6-K | — | 2023-04-11 | — | |
| 6-K | — | 2023-04-03 | — | |
| 6-K | — | 2023-04-03 | — | |
| 6-K | — | 2023-03-30 | — | |
| 6-K | — | 2023-03-28 | — | |
| 6-K | — | 2023-03-21 | — | |
| 6-K | — | 2023-03-17 | 2023-03-16 | |
| 6-K | — | 2023-03-13 | — | |
| 6-K | — | 2023-03-09 | — | |
| 6-K | — | 2023-03-06 | — | |
| 6-K | — | 2023-02-28 | — | |
| 6-K | — | 2023-02-16 | — | |
| 6-K | — | 2023-02-15 | — | |
| 6-K | — | 2023-02-06 | — | |
| 6-K | — | 2023-01-26 | — | |
| 6-K | — | 2023-01-25 | — | |
| 6-K | — | 2023-01-24 | — | |
| 6-K | — | 2023-01-03 | — | |
| 6-K/A | — | 2022-12-27 | — | |
| 6-K | — | 2022-12-20 | — | |
| 6-K | — | 2022-12-12 | — | |
| 6-K | — | 2022-12-06 | — | |
| 6-K | — | 2022-12-05 | — | |
| 6-K | — | 2022-12-05 | — | |
| 6-K | — | 2022-12-02 | — | |
| 6-K | — | 2022-12-01 | — | |
| 6-K | — | 2022-11-29 | — | |
| 6-K | — | 2022-11-17 | — | |
| 6-K | — | 2022-11-14 | — | |
| 6-K | — | 2022-11-14 | — | |
| 6-K | — | 2022-11-10 | — | |
| 6-K | — | 2022-11-07 | 2022-06-30 | |
| 6-K/A | — | 2022-11-07 | — | |
| 6-K | — | 2022-11-04 | — | |
| 6-K | — | 2022-10-26 | — | |
| 6-K | — | 2022-10-19 | — | |
| 6-K | — | 2022-10-18 | — | |
| 6-K | — | 2022-10-14 | — | |
| 6-K | — | 2022-10-03 | — | |
| 6-K | — | 2022-09-23 | — | |
| 6-K | — | 2022-09-16 | — |
Showing 151–200 of 382 filings